To achieve a consistent boost of NK cells IL-15 needs to be administered continuously, but constant exposure of NK cells with IL-15 can cause their exhaustion, decreased viability, and impairment of anti-tumor activity (55, 56). Here, IL15 is linked to neoplasm.